Cancer
New research published online in JNCCN—Journal of the National Comprehensive Cancer Network has found that patients with stage III or IV cancer who quit smoking gained nearly a full year of additional life over their counterparts who continued smoking. The study, which tracked over 13,000 individuals with cancer,
Biotechnology
Cancer remains a leading global health burden, with mRNA cancer vaccines emerging as a transformative approach in cancer immunotherapy. These vaccines, propelled by rapid development, manufacturing flexibility, and proven efficacy against infectious diseases, have begun to show significant advantages over traditional methods. However, challenges related to mRNA instability and in
Cancer research
Researchers at the National Cancer Center of China have made a breakthrough in refining and personalizing the use of consolidation immunotherapy in patients with limited-stage small cell lung cancer (LS-SCLC). A study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC)
Cancer research
Research led by Stanford Medicine has revealed that small cell lung cancer cells that metastasize to the brain form functional connections with neurons, leading to increased tumor growth. This interaction is driven by the electrical pulses from the neurons, which promotes cancer cell growth. The study highlights the critical role
Cancer research
Imagine your body's immune defenses as a city, with lymph nodes as the hubs where police and firefighters gather fresh intel to launch their attack on cancer cells. Recent research is challenging the long-standing practice of removing lymph nodes during cancer surgery. Surgeons have traditionally removed these nodes
Cancer research
Researchers at the Affiliated Hospital of Guizhou Medical University have launched a clinical trial to explore the effectiveness of a patient-perioperative self-management health education program for patients undergoing laparoscopic colorectal cancer surgery. The program aims to enhance patients' awareness, motivation, and self-efficacy for self-management during the perioperative period. The
Cancer research
Current study results on solid cancer have been published, detailing the efficacy of ulevostinag, a cyclic dinucleotide stimulator of IFN genes (STING) agonist, in combination with pembrolizumab in treating advanced or metastatic solid tumors or lymphomas. The research, conducted by the Institute for Cancer Research, involved two clinical trials: a
Cancer research
Researchers at the Roswell Park Comprehensive Cancer Center have reported positive results from a phase II clinical trial examining the efficacy of TAS-102, irinotecan, and bevacizumab in treating patients with pre-treated, advanced colorectal adenocarcinoma. The study found that the combination of these three treatments resulted in a median progression-free survival
Cancer research
A new study published in the European Journal of Cancer has investigated sex-specific survival differences in metastatic melanoma patients who received first-line therapy. The prospective multicenter DeCOG skin cancer registry ADOREG included 2032 patients, with 1274 males (62.7%) and 758 females (37.3%), who received immune checkpoint inhibition (ICI)
Cancer research
Recent research published in Open Life Sciences investigates the combination of immunotherapy and whole-brain radiotherapy in treating patients with multiple brain metastases. Investigators from the Affiliated Cancer Hospital of Nanjing Medical University conducted a retrospective cohort study involving 57 patients diagnosed with brain metastases between 2021 and 2023. The study
Cancer research
Research conducted by a team of scientists at Qingdao University has led to the development of a novel synergistic chemo-immunotherapy platform for breast cancer treatment. The study, published in the journal Colloid and Interface Science Communications, aimed to create a nanosystem that could co-encapsulate phloretin (PHL) and Mn2+ ions, utilizing
Cancer research
The Breast Cancer pipeline landscape has witnessed the emergence of numerous therapeutic innovations and companies working towards developing potential treatments for this prevalent disease. DelveInsight's comprehensive report, "Breast Cancer Pipeline Insight 2025", provides a detailed analysis of 250+ Breast Cancer companies and 300+ pipeline drugs, offering
